However if we combine these two drugs (at the same respective levels) we obtain significant improvement of over anti-TGF-β alone, especially in the case of severe case of IPF, as seen in the bottom curves in Figs 5 and 7. The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.